{
    "nct_id": "NCT06655324",
    "official_title": "A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants.",
    "inclusion_criteria": "The key inclusion criteria include but are not limited to the following:\n\n* Is in good health before randomization.\n* Has a body mass index (BMI) ≥18 and ≤35 kg/m^2, inclusive.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 30 Years",
    "exclusion_criteria": "The key exclusion criteria include but are not limited to the following:\n\n* Has a confirmed or suspected case of infectious mononucleosis within 12 months prior to enrollment.\n* Has any immunosuppressive medical condition or receive any immunosuppressive therapy.",
    "miscellaneous_criteria": ""
}